Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Forns

Showing results (121-130 of 298) with videos related to

Pageof 30
Sort By:
Hepatology (Baltimore, Md.)|September 26, 2002
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelXavier Forns, Sergi Ampurdanès, Josep M Llovet, et al.
Vaccine|September 6, 2002
DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in miceXiaoying Ma, Xavier Forns, Robin Gutierrez, et al.
Journal of Viral Hepatitis|November 22, 2021
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C eliminationXavier Forns, Joan Colom, Montse García-Retortillo, et al.
Clinical Transplantation|May 9, 2014
Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control studyJosep Martí, Sofia De la Serna, Gonzalo Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2025
From Guidelines to Real-Time Conversation: Expert-Validated Retrieval-Augmented and Fine-Tuned GPT-4 for Hepatitis C ManagementMauro Giuffrè, Nicola Pugliese, Simone Kresevic, et al.
European Journal of Gastroenterology & Hepatology|July 21, 2011
Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapyZoe Mariño, Jose Antonio Carrión, Josep Lluis Bedini, et al.
The Journal of Clinical Psychiatry|September 13, 2012
Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysisMarc Udina, Pere Castellví, José Moreno-España, et al.
The American Journal of Gastroenterology|July 1, 2016
Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Journal of Hepatology|February 17, 2009
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective studyJose A Carrión, Eva Martínez-Bauer, Gonzalo Crespo, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Pageof 30

Showing results (121-130 of 298) with videos related to

Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|September 26, 2002
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelXavier Forns, Sergi Ampurdanès, Josep M Llovet, et al.
Vaccine|September 6, 2002
DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in miceXiaoying Ma, Xavier Forns, Robin Gutierrez, et al.
Journal of Viral Hepatitis|November 22, 2021
Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C eliminationXavier Forns, Joan Colom, Montse García-Retortillo, et al.
Clinical Transplantation|May 9, 2014
Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control studyJosep Martí, Sofia De la Serna, Gonzalo Crespo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2025
From Guidelines to Real-Time Conversation: Expert-Validated Retrieval-Augmented and Fine-Tuned GPT-4 for Hepatitis C ManagementMauro Giuffrè, Nicola Pugliese, Simone Kresevic, et al.
European Journal of Gastroenterology & Hepatology|July 21, 2011
Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapyZoe Mariño, Jose Antonio Carrión, Josep Lluis Bedini, et al.
The Journal of Clinical Psychiatry|September 13, 2012
Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysisMarc Udina, Pere Castellví, José Moreno-España, et al.
The American Journal of Gastroenterology|July 1, 2016
Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Journal of Hepatology|February 17, 2009
Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective studyJose A Carrión, Eva Martínez-Bauer, Gonzalo Crespo, et al.
The American Journal of Gastroenterology|April 6, 2016
Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing AgentsMitchell L Shiffman, Vinod Rustgi, Michael Bennett, et al.
Pageof 30